Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME® trial
Kadowaki, Takashi, Nangaku, Masaomi, Hantel, Stefan, Okamura, Tomoo, Eynatten, Maximilian, Wanner, Christoph, Koitka‐Weber, Audrey
Published in Journal of diabetes investigation (01.05.2019)
Published in Journal of diabetes investigation (01.05.2019)
Get full text
Journal Article
Hormone and glucose signalling in POMC and AgRP neurons
Belgardt, Bengt F., Okamura, Tomoo, Brüning, Jens C.
Published in The Journal of physiology (15.11.2009)
Published in The Journal of physiology (15.11.2009)
Get full text
Journal Article
Ubiquitination-Deubiquitination by the TRIM27-USP7 Complex Regulates Tumor Necrosis Factor Alpha-Induced Apoptosis
Zaman, Mohammad Mahabub-Uz, Nomura, Teruaki, Takagi, Tsuyoshi, Okamura, Tomoo, Jin, Wanzhu, Shinagawa, Toshie, Tanaka, Yasunori, Ishii, Shunsuke
Published in Molecular and Cellular Biology (01.12.2013)
Published in Molecular and Cellular Biology (01.12.2013)
Get full text
Journal Article
MyD88 Signaling in the CNS Is Required for Development of Fatty Acid-Induced Leptin Resistance and Diet-Induced Obesity
Kleinridders, André, Schenten, Dominik, Könner, A. Christine, Belgardt, Bengt F., Mauer, Jan, Okamura, Tomoo, Wunderlich, F. Thomas, Medzhitov, Ruslan, Brüning, Jens C.
Published in Cell metabolism (01.10.2009)
Published in Cell metabolism (01.10.2009)
Get full text
Journal Article
Perilipin 5, a Lipid Droplet-binding Protein, Protects Heart from Oxidative Burden by Sequestering Fatty Acid from Excessive Oxidation
Kuramoto, Kenta, Okamura, Tomoo, Yamaguchi, Tomohiro, Nakamura, Tomoe Y., Wakabayashi, Shigeo, Morinaga, Hidetaka, Nomura, Masatoshi, Yanase, Toshihiko, Otsu, Kinya, Usuda, Nobuteru, Matsumura, Shigenobu, Inoue, Kazuo, Fushiki, Tohru, Kojima, Yumiko, Hashimoto, Takeshi, Sakai, Fumie, Hirose, Fumiko, Osumi, Takashi
Published in The Journal of biological chemistry (06.07.2012)
Published in The Journal of biological chemistry (06.07.2012)
Get full text
Journal Article
Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial
Kaku, Kohei, Haneda, Masakazu, Sakamaki, Hiroyuki, Yasui, Atsutaka, Murata, Tatsunori, Ustyugova, Anastasia, Chin, Rina, Hirase, Tetsuaki, Shibahara, Tsunehisa, Hayashi, Naoyuki, Kansal, Anuraag, Kaspers, Stefan, Okamura, Tomoo
Published in Clinical therapeutics (01.10.2019)
Published in Clinical therapeutics (01.10.2019)
Get full text
Journal Article
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials
Yabe, Daisuke, Yasui, Atsutaka, Ji, Linong, Lee, Moon‐Kyu, Ma, Ronald Ching Wan, Chang, Tien‐Jyun, Okamura, Tomoo, Zeller, Cordula, Kaspers, Stefan, Lee, Jisoo, Kohler, Sven, Seino, Yutaka
Published in Journal of diabetes investigation (01.03.2019)
Published in Journal of diabetes investigation (01.03.2019)
Get full text
Journal Article
Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial
Kadowaki, Takashi, Wang, Guang, Rosenstock, Julio, Yabe, Daisuke, Peng, Yongde, Kanasaki, Keizo, Mu, Yiming, Mattheus, Michaela, Keller, Annett, Okamura, Tomoo, Johansen, Odd Erik, Marx, Nikolaus
Published in Diabetology international (01.01.2021)
Published in Diabetology international (01.01.2021)
Get full text
Journal Article
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
Inagaki, Nobuya, Yang, Wenying, Watada, Hirotaka, Ji, Linong, Schnaidt, Sven, Pfarr, Egon, Okamura, Tomoo, Johansen, Odd Erik, George, Jyothis T., von Eynatten, Maximilian, Rosenstock, Julio, Perkovic, Vlado, Wanner, Christoph, Cooper, Mark E., Alexander, John H., Komuro, Issei, Nangaku, Masaomi
Published in Diabetology international (01.04.2020)
Published in Diabetology international (01.04.2020)
Get full text
Journal Article
Drosophila ATF-2 Regulates Sleep and Locomotor Activity in Pacemaker Neurons
Shimizu, Hideyuki, Shimoda, Masami, Yamaguchi, Terumi, Seong, Ki-Hyeon, Okamura, Tomoo, Ishii, Shunsuke
Published in Molecular and Cellular Biology (01.10.2008)
Published in Molecular and Cellular Biology (01.10.2008)
Get full text
Journal Article
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes
Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo
Published in Diabetes therapy (01.04.2018)
Published in Diabetes therapy (01.04.2018)
Get full text
Journal Article
Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance
Ito, Tomohiro, Naito, Yusuke, Shimmoto, Naoki, Ochiai, Kaori, Hayashi, Naoyuki, Okamura, Tomoo
Published in Expert opinion on drug safety (04.03.2021)
Published in Expert opinion on drug safety (04.03.2021)
Get full text
Journal Article
Long-term safety and effectiveness of linagliptin by baseline body mass index in Japanese patients with type 2 diabetes: a 3-year post-marketing surveillance study
Yabe, Daisuke, Yamamoto, Fumiko, Lund, Søren S., Okamura, Tomoo, Kadowaki, Takashi
Published in Expert opinion on drug safety (03.10.2022)
Published in Expert opinion on drug safety (03.10.2022)
Get full text
Journal Article
Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trials
Shiba, Teruo, Ishii, So, Okamura, Tomoo, Mitsuyoshi, Rika, Pfarr, Egon, Koiwai, Kazuki
Published in Diabetes research and clinical practice (01.09.2017)
Published in Diabetes research and clinical practice (01.09.2017)
Get full text
Journal Article
Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis
Kadowaki, Takashi, Yamamoto, Fumiko, Taneda, Yusuke, Naito, Yusuke, Clark, Douglas, Lund, Søren S., Okamura, Tomoo, Kaku, Kohei
Published in Expert opinion on drug safety (03.06.2021)
Published in Expert opinion on drug safety (03.06.2021)
Get full text
Journal Article
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
Yamamoto, Fumiko, Unno, Yuriko, Okamura, Tomoo, Ikeda, Rie, Ochiai, Kaori, Hayashi, Naoyuki
Published in Diabetes therapy (01.01.2020)
Published in Diabetes therapy (01.01.2020)
Get full text
Journal Article
Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial
Watada, Hirotaka, Sakamaki, Hiroyuki, Yabe, Daisuke, Yamamoto, Fumiko, Murata, Tatsunori, Hanada, Keigo, Hirase, Tetsuaki, Okamura, Tomoo
Published in Diabetes therapy (01.08.2020)
Published in Diabetes therapy (01.08.2020)
Get full text
Journal Article
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
Yamamoto, Fumiko, Ikeda, Rie, Ochiai, Kaori, Hirase, Tetsuaki, Hayashi, Naoyuki, Okamura, Tomoo
Published in Diabetes therapy (01.02.2020)
Published in Diabetes therapy (01.02.2020)
Get full text
Journal Article